These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. [Venous thromboembolic pathology. New acquired risk factors or new data on acquired risk factors]. Drouet L Arch Mal Coeur Vaiss; 2001 Nov; 94(11 Suppl):1318-26. PubMed ID: 11794976 [TBL] [Abstract][Full Text] [Related]
3. [Genetic risk factors of venous thromboembolism]. Oner F; Kaya A; Doğan R; Numanoğlu N Tuberk Toraks; 2003; 51(1):60-9. PubMed ID: 15100907 [TBL] [Abstract][Full Text] [Related]
6. Activated protein C resistance--a major risk factor for thrombosis. Rosén SB; Sturk A Eur J Clin Chem Clin Biochem; 1997 Jul; 35(7):501-16. PubMed ID: 9263726 [TBL] [Abstract][Full Text] [Related]
7. Interrelation of hyperhomocysteinemia and inherited risk factors for venous thromboembolism. Results from the E.D.I.TH. study: a hospital-based case-control study. Oger E; Lacut K; Le Gal G; Couturaud F; Abalain JH; Mercier B; Mottier D; Thromb Res; 2007; 120(2):207-14. PubMed ID: 17126889 [TBL] [Abstract][Full Text] [Related]
8. [From gene to disease; risk factors for venous thrombosis: factor V Leiden and prothrombin 20210A]. Reitsma PH; van de Stolpe A Ned Tijdschr Geneeskd; 2001 Sep; 145(38):1843-5. PubMed ID: 11593787 [TBL] [Abstract][Full Text] [Related]
9. Inherited thrombophilia and first venous thromboembolism during pregnancy and puerperium. Martinelli I; De Stefano V; Taioli E; Paciaroni K; Rossi E; Mannucci PM Thromb Haemost; 2002 May; 87(5):791-5. PubMed ID: 12038778 [TBL] [Abstract][Full Text] [Related]
10. [Venous thromboembolic disease: which coagulation screening, for whom, when?]. Wautrecht JC Rev Med Brux; 2005 Sep; 26(4):S315-9. PubMed ID: 16240880 [TBL] [Abstract][Full Text] [Related]
11. Venous thromboembolism: implications for gene-based diagnosis and technology development. Hooper WC; De Staercke C Expert Rev Mol Diagn; 2002 Nov; 2(6):576-86. PubMed ID: 12465454 [TBL] [Abstract][Full Text] [Related]
12. Effect of Factor V Leiden and prothrombin G20210-->A mutations on thromboembolic risk in the national surgical adjuvant breast and bowel project breast cancer prevention trial. Abramson N; Costantino JP; Garber JE; Berliner N; Wickerham DL; Wolmark N J Natl Cancer Inst; 2006 Jul; 98(13):904-10. PubMed ID: 16818854 [TBL] [Abstract][Full Text] [Related]
13. Risk factors and recurrence rate of primary deep vein thrombosis of the upper extremities. Martinelli I; Battaglioli T; Bucciarelli P; Passamonti SM; Mannucci PM Circulation; 2004 Aug; 110(5):566-70. PubMed ID: 15262837 [TBL] [Abstract][Full Text] [Related]
14. Minor events and the risk of deep venous thrombosis. Eekhoff EM; Rosendaal FR; Vandenbroucke JP Thromb Haemost; 2000 Mar; 83(3):408-11. PubMed ID: 10744145 [TBL] [Abstract][Full Text] [Related]